In this week's episode of Compound Wisdom, host Steve sits down with Anthony Kantor — co-founder and operator of Ivím Health — to dig into one of the most overlooked secrets in telehealth: building something that actually works for patients, not just for growth metrics.

Anthony shares how he and his brother, Taylor, bootstrapped a family-run telehealth company from the ground up, pivoted into the GLP-1 wave at exactly the right moment, and built a high-touch care model by keeping providers in-house when everyone else was outsourcing.

Anthony explains why they started with peptides after his mom's Crohn's remission on BPC-157, how a single TikTok video took them from 15 patients to 150 in a month, and why they turned down external provider networks to maintain full control over patient experience.

They also get into the messier side of scaling — what it's really like visiting compounding pharmacies in person, why female HRT is more symptom-based than people think, and how AI is already changing what providers can handle at scale.

The episode closes with Anthony's belief that the telehealth space is about to see consolidation — and that the companies obsessed with patient outcomes, not exits, are the ones that will survive it.

Takeaways

1. Start by understanding the patient problem deeply — Ivím Health was born from a personal health story, not a market opportunity.

2. Don't chase trends blindly — they almost passed on GLP-1s before understanding the cardio-metabolic benefits.

3. Keeping providers in-house costs more upfront but gives you full control over patient experience and clinical quality.

4. Organic growth beats paid ads early on — Ivím Health didn't spend a dollar on marketing for the first year.

5. Visit your compounding pharmacies in person — if you're putting it in a patient's body, you should know where it comes from.

6. Labs aren't always necessary for female HRT — symptom-based care can be more effective, but patient comfort matters too.

7. Build tech that personalizes the journey, not just the prescription — engagement is what drives outcomes.

8. Use AI to empower providers first, not replace them — the best healthcare will always be a hybrid model.

9. If one compounder is doing something no one else is, that's a red flag, not a competitive advantage.

10. When the mission is bigger than the business opportunity, patient trust becomes your moat.

Chapters

00:00 — Intro: Telehealth consolidation is coming — and why Ivím Health isn't worried

01:27 — The origin story: From Crohn's remission to building a peptide platform

03:29 — How a family of four bootstrapped a telehealth company with zero investors

03:51 — The GLP-1 pivot: Why they almost said no, and what changed their mind

04:53 — From 15 patients to 150 in 30 days: The TikTok moment that changed everything

05:42 — Building for patient experience, not just growth metrics

07:22 — Why Ivím Health keeps all providers in-house — and what that costs

08:31 — The medications they offer now — and why peptides are coming back

09:18 — Female HRT beta learnings: Labs, symptom-based care, and insurance dynamics

11:24 — The peptide landscape in 2024 — what's coming back and when

16:17 — Compounding pharmacy diligence: Why visiting in person matters

17:41 — The seven-pharmacy algorithm — routing prescriptions for speed and quality

18:42 — AI for providers, not patients (yet): How Ivím Health is using automation to scale care

21:05 — Why healthcare will be the last industry to go fully AI — empathy still matters

23:01 — Doubling provider efficiency with AI — from 1:1000 to 1:2000 patient ratios

24:49 — Where telehealth is going: Consolidation, exits, and who stays standing

26:21 — Why Ivím Health isn't looking to cash out — and what kind of partners they'd actually take

28:12 — Final thoughts: Patient outcomes over everything